BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19243021)

  • 1. Down-regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells.
    Ndong Jde L; Jean D; Rousselet N; Frade R
    Int J Cancer; 2009 Jun; 124(11):2597-606. PubMed ID: 19243021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes.
    Kim HJ; Roh MS; Son CH; Kim AJ; Jee HJ; Song N; Kim M; Seo SY; Yoo YH; Yun J
    Cancer Lett; 2012 Aug; 321(2):195-202. PubMed ID: 22342682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB18A enhances expression of mutant p53 protein in human cells.
    Lottin-Divoux S; Barel M; Frade R
    FEBS Lett; 2005 Apr; 579(11):2323-6. PubMed ID: 15848166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procathepsin L secretion, which triggers tumour progression, is regulated by Rab4a in human melanoma cells.
    Barbarin A; Frade R
    Biochem J; 2011 Jul; 437(1):97-107. PubMed ID: 21501115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells.
    Frade R; Rousselet N; Jean D
    Cancer Gene Ther; 2008 Sep; 15(9):591-604. PubMed ID: 18617916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression.
    Vijayvargia R; May MS; Fondell JD
    Cancer Res; 2007 May; 67(9):4034-41. PubMed ID: 17483314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB18A regulates p53-dependent apoptosis.
    Frade R; Balbo M; Barel M
    Oncogene; 2002 Jan; 21(6):861-6. PubMed ID: 11840331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.
    Zhang X; Krutchinsky A; Fukuda A; Chen W; Yamamura S; Chait BT; Roeder RG
    Mol Cell; 2005 Jul; 19(1):89-100. PubMed ID: 15989967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RB18A, whose gene is localized on chromosome 17q12-q21.1, regulates in vivo p53 transactivating activity.
    Frade R; Balbo M; Barel M
    Cancer Res; 2000 Dec; 60(23):6585-9. PubMed ID: 11118038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mediator subunit MED1/TRAP220 is required for optimal glucocorticoid receptor-mediated transcription activation.
    Chen W; Roeder RG
    Nucleic Acids Res; 2007; 35(18):6161-9. PubMed ID: 17827210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.
    Guillaume-Rousselet N; Jean D; Frade R
    Biochem J; 2002 Oct; 367(Pt 1):219-27. PubMed ID: 12241546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1.
    Udayakumar TS; Belakavadi M; Choi KH; Pandey PK; Fondell JD
    J Biol Chem; 2006 May; 281(21):14691-9. PubMed ID: 16574658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53.
    Drané P; Barel M; Balbo M; Frade R
    Oncogene; 1997 Dec; 15(25):3013-24. PubMed ID: 9444950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of TRAP/mediator subunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation.
    Pandey PK; Udayakumar TS; Lin X; Sharma D; Shapiro PS; Fondell JD
    Mol Cell Biol; 2005 Dec; 25(24):10695-710. PubMed ID: 16314496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mediator complex subunit 1 enhances transcription of genes needed for adrenal androgen production.
    Nakamura Y; Xing Y; Sasano H; Rainey WE
    Endocrinology; 2009 Sep; 150(9):4145-53. PubMed ID: 19497978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mediator complex functions as a coactivator for GATA-1 in erythropoiesis via subunit Med1/TRAP220.
    Stumpf M; Waskow C; Krötschel M; van Essen D; Rodriguez P; Zhang X; Guyot B; Roeder RG; Borggrefe T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18504-9. PubMed ID: 17132730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
    Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells.
    Gade P; Singh AK; Roy SK; Reddy SP; Kalvakolanu DV
    Int J Cancer; 2009 Oct; 125(7):1566-74. PubMed ID: 19521987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED1 Downregulation Contributes to TGFβ-Induced Metastasis by Inhibiting SMAD2 Ubiquitination Degradation in Cutaneous Melanoma.
    Li Y; Wu J; Tian Y; Zhu Q; Ge Y; Yu H; Huang J; Li H; Zhang J; Zhang L; Hu L
    J Invest Dermatol; 2022 Aug; 142(8):2228-2237.e4. PubMed ID: 35131256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.